ReGeneraTing Agents (rgta®) technology combined with antibiotics improves outcomes for infections in the upper limb

Abstract

Abstract A matrix therapy agent marketed as CACIPLIQ20® showed marked improvement in the healing rate of hand infections, including functional recovery. It can be used at both earlier and later stages to promote faster healing and prevent an adverse outcome.

Keywords

• CACIPLIQ20®
• heparan sulfate mimetic
• infection
• matrix therapy
• wound healing